Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.10339
Abstract: Key Points Question What is the recommended dose of difelikefalin, a κ-opioid receptor agonist, in Japanese patients with moderate to severe pruritus receiving hemodialysis? Findings In this phase 2 randomized clinical trial of 247 patients,…
read more here.
Keywords:
receiving hemodialysis;
severe pruritus;
safety;
moderate severe ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Pharmacoepidemiology and drug safety"
DOI: 10.1002/pds.5337
Abstract: PURPOSE Secondary hyperparathyroidism (SHPT) is common among dialysis patients, and calcimimetics are a mainstay of treatment. This study assessed whether cinacalcet use is associated with gastrointestinal bleeding in a large hemodialysis cohort. METHODS A linked…
read more here.
Keywords:
gastrointestinal bleeding;
receiving hemodialysis;
patients receiving;
use ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "International Urology and Nephrology"
DOI: 10.1007/s11255-020-02600-0
Abstract: Purpose Most patients receiving hemodialysis have perceived difficulty in mobility tasks, such as basic activities of daily living (ADL), ambulation, and walking up or down stairs, even if they can ambulate independently. Perceived difficulty in…
read more here.
Keywords:
difficulty;
adl;
patients receiving;
perceived difficulty ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Vaccine"
DOI: 10.1016/j.vaccine.2021.05.003
Abstract: BACKGROUND Hemodialysis patients are at increased risk of hepatitis B virus (HBV) infection and are poorly responsive to HBV vaccines. Current vaccine recommendations for hemodialysis patients utilize more than twice the amount of hepatitis B…
read more here.
Keywords:
hemodialysis;
hepb cpg;
hepatitis;
receiving hemodialysis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-66182-8
Abstract: Data regarding the efficacy and tolerability of elbasvir/grazoprevir (EBR/GZR) for East-Asian hepatitis C virus genotype 1b (HCV GT1b) patients receiving hemodialysis were limited. We prospectively recruited 40 HCV GT1b hemodialysis patients who received EBR/GZR for…
read more here.
Keywords:
hemodialysis;
ebr gzr;
treatment;
patients receiving ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfy055
Abstract: ABSTRACT Background Vadadustat, an inhibitor of hypoxia-inducible factor prolyl-4-hydroxylase domain dioxygenases, is an oral investigational agent in development for the treatment of anemia secondary to chronic kidney disease. Methods In this open-label Phase 2 trial,…
read more here.
Keywords:
hemodialysis;
receiving hemodialysis;
effects vadadustat;
dose cohorts ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Bioscience of Microbiota, Food and Health"
DOI: 10.12938/bmfh.16-009
Abstract: Patients receiving hemodialysis also manifest gastrointestinal symptoms, such as constipation, caused by restriction of water intake and the loss of body water balance. Because dietary carnitine deficiency is considered to cause smooth muscle dysmotility of…
read more here.
Keywords:
gastrointestinal disorders;
hemodialysis;
patients receiving;
carnitine improves ... See more keywords